Venus Remedies Limited has submitted a regulatory disclosure to the National Stock Exchange of India Ltd. and BSE Limited regarding a shareholder communication initiative.
The company has undertaken an awareness campaign through posts published on its official social media handles to sensitize and encourage shareholders to update their KYC details. The campaign was conducted across four social media platforms: Instagram, Facebook, LinkedIn, and X (formerly Twitter).
The disclosure includes direct links to each social media post:
- Facebook: https://www.facebook.com/share/p/1En65QDBpp/
- Instagram: https://www.instagram.com/p/Da7ILEGIEQ7/?utmsource=igwebcopylink&igsh=MzRIODBiNWFIZA==
- LinkedIn: https://www.linkedin.com/feed/update/urn:li:activity:7484117081190187008
- X: https://x.com/remediesvenus/status/2078364116251787277?s=20
The document was digitally signed by Neha, Company Secretary (Membership No. F8374) on 18.07.2026 at 17:23:23 IST. The company's corporate office is located at 51-52, Industrial Area, Phase-I, Panchkula, Haryana 134113, India, with registered office at SCO 857, Cabin No. 10, 2nd Floor, NAC, Manimajra, Chandigarh (U.T.) 160101, India. The company also maintains operations in Baddi, Himachal Pradesh and Werne, Germany through Venus Pharma GmbH.
No financial impact, quantitative metrics, or operational consequences were disclosed in this filing. The communication is purely informational regarding shareholder compliance awareness efforts.